Back to Search Start Over

Treatment of NF1-Associated Optic Pathway/Hypothalamic Gliomas in Patients With Diencephalic Syndrome.

Authors :
Weiser A
Hengartner H
Kottke R
Grehten P
Toelle SP
Gerber NU
Grotzer MA
Guerreiro Stucklin AS
Source :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2023 May 01; Vol. 45 (4), pp. e543-e546. Date of Electronic Publication: 2022 Oct 20.
Publication Year :
2023

Abstract

Diencephalic syndrome is usually associated with tumors in the hypothalamic region, rarely occurring in patients with neurofibromatosis type 1 (NF1)-associated gliomas. We describe the clinical presentation and response to treatment in 3 patients with NF1 presenting with diencephalic syndrome as first symptom of optic pathway/hypothalamic glioma (OPHG). Because of the rarity of this constellation, knowledge about the clinical course and best treatment options for patients with NF1-associated OPHG and diencephalic syndrome is still limited. All 3 patients showed good response to treatment with normalization of body mass index and decrease in tumor volume within 6 months.<br />Competing Interests: The authors declare no conflict of interest.<br /> (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.)

Details

Language :
English
ISSN :
1536-3678
Volume :
45
Issue :
4
Database :
MEDLINE
Journal :
Journal of pediatric hematology/oncology
Publication Type :
Academic Journal
Accession number :
36730977
Full Text :
https://doi.org/10.1097/MPH.0000000000002569